21 December 2023
Latham & Watkins Advises on Worldwide Clinical Trials’ Completed Recapitalization With Kohlberg & Company
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Stelios Saffos Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Pete Sluka Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Andrew Blumenthal Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Ian Lachow | Latham & Watkins LLP | Associate | capital markets | New York |
| Emma Gilmore | Latham & Watkins LLP | Associate | capital markets | New York |
| Pardis Zomorodi | Latham & Watkins LLP | Partner | tax | Century City |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Not stated
- Counterparties
- Worldwide Clinical Trials (Target)
Kohlberg & Company, LLC (Buy-side)
TJC (Sell-side)